Perrigo Company PLC
NYSE:PRGO
Perrigo Company PLC
NYSE:PRGO
Price:
32.89 USD
-0.51%
Updated:
May 3, 2024
Perrigo Company PLC
Cash from Operating Activities
|
Perrigo Company PLC
Cash from Operating Activities Peer Comparison
Comparables:
JAZZ
AVDL
G
GHRS
COPN
OVB
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Perrigo Company PLC
NYSE:PRGO
|
Cash from Operating Activities
$405.5m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-3%
|
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Cash from Operating Activities
$1.1B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
14%
|
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Cash from Operating Activities
-$128.5m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-20%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Cash from Operating Activities
-$33.3m
|
CAGR 3-Years
-366%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Cash from Operating Activities
€33.6m
|
CAGR 3-Years
37%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
15%
|
|
|
Ovoca Bio PLC
LSE:OVB
|
Cash from Operating Activities
-€1.7m
|
CAGR 3-Years
24%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
9%
|
See Also
What is Perrigo Company PLC's Cash from Operating Activities?
Cash from Operating Activities
405.5m
USD
405.5m
USD
Based on the financial report for Dec 31, 2023, Perrigo Company PLC's Cash from Operating Activities amounts to 405.5m USD.
What is Perrigo Company PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-3%
-3%
Over the last year, the Cash from Operating Activities growth was 32%. The average annual Cash from Operating Activities growth rates for Perrigo Company PLC have been -14% over the past three years , -7% over the past five years , and -3% over the past ten years .
You don't have any saved screeners yet
